MMMarian J. Menke

Marian J. Menke

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marian J. Menke has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Identification and Engineering of Novel N ‐Methyltransferases

    by Florian Heinz, Hannes Meinert, Ina Somvilla, Marian J. Menke, Mark Doerr, Thomas Bayer, Uwe T. Bornscheuer

    The methylation of small molecules is of immense value to various chemical industries. Since chemical alkylation requires rather unselective and harsh reaction conditions, sustainable biocatalytic approaches are highly desired. Methyltransferases, particularly N ‐methyltransferases (NMTs), facilitate the selective introduction of methyl (and other alkyl) groups under mild conditions in aqueous solution and are a promising alternative to chemical synthesis. In this work, we expanded the toolbox of NMTs through the bioinformatic‐assisted mining of databases and the high‐throughput characterization of novel NMTs by a fluorescence‐based assay. The latter can assess enzyme activity in cell lysates, independent of the investigated substrate, and was used to guide the engineering of newly identified NMTs. Mutants, exhibiting up to 8‐fold improved selective methylation of (non‐)natural N ‐heterocyclic drug precursors, were identified and promise great potential for synthetic applications.


  • Open Access

    Data‐Driven Protein Engineering for Improving Catalytic Activity and Selectivity

    by Yu‐Fei Ao, Mark Dörr, Marian J. Menke, Stefan Born, Egon Heuson, Uwe T. Bornscheuer

    Protein engineering is essential for altering the substrate scope, catalytic activity and selectivity of enzymes for applications in biocatalysis. However, traditional approaches, such as directed evolution and rational design, encounter the challenge in dealing with the experimental screening process of a large protein mutation space. Machine learning methods allow the approximation of protein fitness landscapes and the identification of catalytic patterns using limited experimental data, thus providing a new avenue to guide protein engineering campaigns. In this concept article, we review machine learning models that have been developed to assess enzyme‐substrate‐catalysis performance relationships aiming to improve enzymes through data‐driven protein engineering. Furthermore, we prospect the future development of this field to provide additional strategies and tools for achieving desired activities and selectivities.


  • Open Access

    Ein universeller, kontinuierlicher Assay für SAM‐abhängige Methyltransferasen

    by Marian J. Menke, Pascal Schneider, Christoffel P. S. Badenhorst, Andreas Kunzendorf, Florian Heinz, Mark Dörr, Martin A. Hayes, Uwe T. Bornscheuer

    Die enzymkatalysierte Funktionalisierung (engl.: late‐stage functionalization (LSF)), wie z. B. die Methylierung von Arzneimittelmolekülen und Leitstrukturen, ermöglicht den direkten Zugang zu wirksameren pharmazeutischen Wirkstoffen (API). S‐Adenosyl‐l‐Methionin‐abhängige Methyltransferasen (MTs) können eine Schlüsselrolle bei der Entwicklung neuer Wirkstoffe spielen, da sie die chemo‐ und regioselektive Methylierung von O‐, N‐, S‐ und C‐Atomen katalysieren und damit den herkömmlichen chemischen Wegen überlegen sind. Um geeignete MTs zu identifizieren, haben wir einen kontinuierlichen fluoreszenzbasierten Hochdurchsatzassay für SAM‐abhängige Methyltransferasen entwickelt, der das Screening unter Verwendung von E. coli Zelllysaten erleichtert. Dieser Assay besteht aus zwei enzymatischen Schritten für die Umwandlung von S‐Adenosyl‐l‐Homocystein zu H2S, was zu einer selektiven Fluoreszenzmessung durch Reduktion eines Azidocoumarin‐Sulfidsensors führt. Die Untersuchung von zwei O‐MTs und einer N‐MT bestätigte, dass dieser Assay für die Bestimmung der Methyltransferase‐Aktivität in E. coli Zelllysaten geeignet ist.


  • Open Access

    A Universal, Continuous Assay for SAM‐dependent Methyltransferases

    by Marian J. Menke, Pascal Schneider, Christoffel P. S. Badenhorst, Andreas Kunzendorf, Florian Heinz, Mark Dörr, Martin A. Hayes, Uwe T. Bornscheuer

    Enzyme‐catalyzed late‐stage functionalization (LSF), such as methylation of drug molecules and lead structures, enables direct access to more potent active pharmaceutical ingredients (API). S‐adenosyl‐l‐methionine‐dependent methyltransferases (MTs) can play a key role in the development of new APIs, as they catalyze the chemo‐ and regioselective methylation of O‐, N‐, S‐ and C‐atoms, being superior to traditional chemical routes. To identify suitable MTs, we developed a continuous fluorescence‐based, high‐throughput assay for SAM‐dependent methyltransferases, which facilitates screening using E. coli cell lysates. This assay involves two enzymatic steps for the conversion of S‐adenosyl‐l‐homocysteine into H2S to result in a selective fluorescence readout via reduction of an azidocoumarin sulfide probe. Investigation of two O‐MTs and an N‐MT confirmed that this assay is suitable for the determination of methyltransferase activity in E. coli cell lysates.


  • Open Access

    RDM System LARA

    by Mark Doerr, Stefan T. Maak, Marian J. Menke, Uwe T. Bornscheuer

    LARAsuite (https://gitlab.com/larasuite) is a free and open source research data management system that addresses the problematic of manual data insertion and metadata assignment into the corresponding databases by a radically automated processes. Data and Metadata is mainly not inserted by humans, but by the machines producing the data and automatically transferring this generated data and metadata to the LARA RDM system. This data transfer is achieved through the intensive utilisation of the free and open lab-automation standard SiLA (Standardisa- tion in Labautomation) (https://sila-standard.org), combined with a simple to note process description language (pythonLab) and orchestration, scheduling, data aggre- gation and evaluation. Many LARA instances can be selectively synchronised to form a decentralised network of data infrastructures across labs and institutions. Research data and meta-data can be queried by a SPARQL endpoint. As the LARAsuite comes close to an ideal FAIR-principles based RDM System1, is generic to the most common natural science applications, is open source (python based), modular and easy deploy- able, it can be used to showcase NFDI goals for a wide range of scientists

  • Open Access

    Structure‐ and Data‐Driven Protein Engineering of Transaminases for Improving Activity and Stereoselectivity

    by Yu‐Fei Ao, Shuxin Pei, Chao Xiang, Marian J. Menke, Lin Shen, Chenghai Sun, Mark Dörr, Stefan Born, Matthias Höhne, Uwe T. Bornscheuer

    Amine transaminases (ATAs) are powerful biocatalysts for the stereoselective synthesis of chiral amines. Machine learning provides a promising approach for protein engineering, but activity prediction models for ATAs remain elusive due to the difficulty of obtaining high‐quality training data. Thus, we first created variants of the ATA from Ruegeria sp. (3FCR) with improved catalytic activity (up to 2000‐fold) as well as reversed stereoselectivity by a structure‐dependent rational design and collected a high‐quality dataset in this process. Subsequently, we designed a modified one‐hot code to describe steric and electronic effects of substrates and residues within ATAs. Finally, we built a gradient boosting regression tree predictor for catalytic activity and stereoselectivity, and applied this for the data‐driven design of optimized variants which then showed improved activity (up to 3‐fold compared to the best variants previously identified). We also demonstrated that the model can predict the catalytic activity for ATA variants of another origin by retraining with a small set of additional data.


  • Open Access

    Struktur‐ und Daten‐basiertes Protein Engineering von Transaminasen zur Verbesserung von Aktivität und Stereoselektivität

    by Yu‐Fei Ao, Shuxin Pei, Chao Xiang, Marian J. Menke, Lin Shen, Chenghai Sun, Mark Dörr, Stefan Born, Matthias Höhne, Uwe T. Bornscheuer

    Amintransaminasen (ATAs) sind leistungsstarke Biokatalysatoren für die stereoselektive Synthese chiraler Amine. Machine learning ist ein vielversprechender Ansatz für das Protein‐Engineering, aber Modelle zur Aktivitätsvorhersage für ATAs sind aufgrund der Schwierigkeit, qualitativ hochwertige Trainingsdaten zu erhalten, schwer zu finden. Aus diesem Grund haben wir zunächst Varianten der ATA aus Ruegeria sp. (3FCR) mit verbesserter katalytischer Aktivität (bis zu 2000‐fach) sowie umgekehrter Stereoselektivität durch strukturabhängiges rationales Design entwickelt und dabei einen hochwertigen Datensatz gesammelt. Anschließend entwarfen wir einen modifizierten One‐Hot‐Code, um sterische und elektronische Effekte von Substraten und Aminosäureresten innerhalb von ATAs zu beschreiben. Schließlich erstellten wir einen Gradient Boosting Regression Tree Prädiktor zur Vorhersage der katalytischen Aktivität und Stereoselektivität und wendeten diesen für das datengesteuerte Design optimierter Varianten an, die dann eine verbesserte Aktivität zeigten (bis zum Dreifachen im Vergleich zu den besten zuvor identifizierten Varianten). Wir haben zudem gezeigt, dass das Modell die katalytische Aktivität für ATA‐Varianten eines anderen Enzyms vorhersagen kann, indem es mit einem kleinen Satz zusätzlicher Daten neu trainiert wurde.


  • Open Access

    Development of an Ontology for Biocatalysis

    by Marian J. Menke, Alexander S. Behr, Katrin Rosenthal, David Linke, Norbert Kockmann, Uwe T. Bornscheuer, Mark Dörr